Fulton Financial director proposes $118K share sale

Raymond James & Associates, Inc. is named as broker, and the notice lists an August 7, 2026 plan-adoption or instruction date if relying on Rule 10b5-1.

Available on EDGAR 11/09/2026 - 03:50 PM EST Accepted by SEC EDGAR 11/09/2026 - 03:49 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Fulton Financial Corp. director E. Philip Wenger reported a proposed sale of 5,000 common shares, with an aggregate market value of $118,450 and an approximate sale date of November 6, 2026. Raymond James & Associates, Inc. is named as broker. Remarks describe the sale as from an IRA; the securities table says the shares were acquired January 1, 2009, through 401(k) contributions.

Separately, the notice lists Hospice & Community Care as having sold 250 common shares on November 5, 2026, for gross proceeds of $5,947. Rashida Mitchell signed as a duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for E. Philip Wenger.

Key Figures

Proposed sale: 5,000 common shares Aggregate market value: $118,450 Shares sold: 250 common shares +2 more

5 metrics

Proposed sale 5,000 common shares E. Philip Wenger; approximate sale date November 6, 2026

Aggregate market value $118,450 Proposed sale of 5,000 common shares

Shares sold 250 common shares Hospice & Community Care; November 5, 2026

Gross proceeds $5,947 Hospice & Community Care sale on November 5, 2026

Shares outstanding 189,274,285 shares Issuer shares outstanding reported in the notice

Key Terms

Aggregate Market Value, Rule 10b5-1, Gross Proceeds

3 terms

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Rule 10b5-1 regulatory

"If Relying on Rule 10b5-1"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Gross Proceeds financial

"Amount of Securities Sold | Gross Proceeds"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many FULT shares does E. Philip Wenger plan to sell?

The notice reports a proposed sale of 5,000 common shares, with an aggregate market value of $118,450 and an approximate sale date of November 6, 2026.

What date does FULT's Form 144 list for a Rule 10b5-1 plan?

The notice lists August 7, 2026 as the date of plan adoption or giving of instruction if relying on Rule 10b5-1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001347709
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	FULTON FINANCIAL CORP
SEC File Number	001-39680
Address of Issuer	ONE PENN SQ PO BOX 4887 LANCASTER PENNSYLVANIA 17604
Phone	7172912411
Name of Person for Whose Account the Securities are To Be Sold	Wenger E Philip
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates, Inc. 880 Carillon Parkway St. Petersburg, FL 33716	5000	118450.00	189274285	11/06/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2009	Purchased in 401(k) with contributions	Issuer			5000	12/31/2009	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Hospice & Community Care, 85 Good Drive PO Box 412 Lancaster, PA 17604	Common	11/05/2026	250	5947.00

144: Remarks and Signature

Remarks	Selling 5000 shares from IRA Affiliate gifted a total of 250 shares to cover the above entity.
Date of Notice	11/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/07/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for E Philip Wenger
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)